Showing results (121-130 of 182) with videos related to
Sort By:
Pageof 19
The Journal of Clinical Endocrinology and Metabolism|October 13, 2006
Dopamine receptor expression and function in corticotroph ectopic tumorsRosario Pivonello, Diego Ferone, Wouter W de Herder, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 23, 2018
Correlation of dose with toxicity and tumour response to <sup>90</sup>Y- and <sup>177</sup>Lu-PRRT provides the basis for optimization through individualized treatment planningMarta Cremonesi, Mahila Esmeralda Ferrari, Lisa Bodei, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2014
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factorsLisa Bodei, Mark Kidd, Giovanni Paganelli, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2011
Peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE: the IEO phase I-II studyLisa Bodei, Marta Cremonesi, Chiara M Grana, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2026
MIRD Pamphlet No. 34, Part 2: Benchmarking of MIRDct Software for CT Organ Dose EstimationGunjan Kayal, Juan Camilo Ocampo Ramos, Laura E Dinwiddie, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2004
Clinical feasibility of two-step streptavidin/111In-biotin scintigraphy in patients with suspected vertebral osteomyelitisElena Lazzeri, Ernest K J Pauwels, Paola A Erba, et al.Journal of Thoracic Disease|December 5, 2017
Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasmsIrvin M Modlin, Mark Kidd, Pier-Luigi Filosso, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
MIRD Pamphlet No. 34, Part 1: MIRDct-A Customizable Software Tool for CT DosimetryJuan Camilo Ocampo Ramos, Cameron Kofler, Robert Dawson, et al.Frontiers in Oncology|September 6, 2014
Radioembolization of hepatic lesions from a radiobiology and dosimetric perspectiveMarta Cremonesi, Carlo Chiesa, Lidia Strigari, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2016
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with <sup>177</sup>Lu-D OTATATEMaddalena Sansovini, Stefano Severi, Annarita Ianniello, et al.Pageof 19